Trials / Withdrawn
WithdrawnNCT00674141
Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment
Nasal Administration of Dexamethasone for MS Treatment
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone soduim phosphate | nasale administation of Dexamethasone in 20mg dose/day (in two divided doses) fpr sevem days of treatment |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2008-12-01
- Completion
- 2009-01-01
- First posted
- 2008-05-07
- Last updated
- 2010-06-03
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00674141. Inclusion in this directory is not an endorsement.